The prestigious medical center Georgetown University at Washington DC has sign a contract with ISK to run a clinical trial with patients with mtKRAS pancreas and colon cancers.
Recent Posts
- Update from AML human trial in Miami
- Georgetown University at Washington DC has signed a contract with ISK to run a clinical trial with patients with mtKRAS tumors
- PHASE 1B/2A Clinical trial started
- ISK received the FDA’s approval to start Phase 1b/2a with AML patients
- Cooperation with Harvard Medical School (MGH)